Idexx Laboratories | IDXX - Debt


Idexx Laboratories reported $1.11B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
Align Technology USD 114.45M 6.82M Dec/2025
AngioDynamics USD 6.3M 6.3M Feb/2025
Dentsply International USD 2.33B 137M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Fujifilm JPY 922.82B 236.91B Sep/2025
Globus Medical USD 118.66M 687K Dec/2025
Henry Schein USD 3.75B 313M Mar/2026
Idexx Laboratories USD 1.11B 129.39M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Neogen USD 792.93M 396K Sep/2025
Orthofix International USD 137.23M 338K Sep/2024
Phibro Animal Health USD 474.17M 730K Sep/2024
ResMed USD 847.72M 1.37M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Steris USD 2.05B 4.8M Dec/2025
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Teleflex USD 2.73B 43.5M Dec/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Zoetis USD 9.24B 1.96B Dec/2025